PARSIPPANY, N.J., Dec. 01, 2023 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company, today issued the following statement regarding the U.S. Food and ...

Dublin, Nov. 01, 2024 (GLOBE NEWSWIRE) -- The "Enteral Syringe Market: Market Size, Trends, Opportunities and Forecast by Application, End-User, Product Type, Region, By Country: 2020-2030" report ...

Global Safety Syringes Market is valued at approximately USD 7096.94 million in 2022 and is anticipated to grow with a healthy growth rate of more than 4.5% during the forecast period 2023-2030.

The global safety syringes market, valued at approximately USD 7.1 billion in 2022, is projected to grow at a steady compound annual growth rate (CAGR) of over 4.5% during the forecast period from ...

People with type 1 diabetes, and occasionally those with type 2 diabetes, need to take insulin to maintain blood sugar levels. Insulin can be given in different ways: syringe, pen , or pump.

There are approximately 425 million people worldwide with diabetes. Approximately 75 million of these inject themselves with insulin daily. Now they may soon have a new alternative to syringes or ...

New medicine can create a new life for diabetes patients -- without needles. ScienceDaily . Retrieved June 2, 2025 from www.sciencedaily.com / releases / 2024 / 01 / 240119122649.htm ...